Intuitive Surgical, Inc. (ISRG) EV/Sales Ratio: 13.87x
Is Intuitive Surgical, Inc.’s EV/Sales ratio high or low?
Intuitive Surgical, Inc.'s EV/Sales ratio of 13.87x is 26% below its 5-year average of 18.69x, near the low end of its 5-year range (10.91x–27.84x).
The EV/Sales ratio for Intuitive Surgical, Inc. (ISRG) is 13.87x as of Wednesday, June 10, 2026. It is below its 12-month average by 24.74% (18.43x).
ISRG EV/Sales Ratio Chart
ISRG Average EV/Sales Ratio Chart
ISRG Current vs Average EV/Sales Ratio Chart
ISRG EV/Sales Ratio Metrics
EV/SALES RATIO
13.87x
EV/SALES RATIO AVG TTM
18.43x
EV/SALES RATIO AVG 3Y
19.52x
EV/SALES RATIO AVG 5Y
18.69x
EV/SALES RATIO AVG 10Y
16.64x
EV/SALES RATIO AVG 15Y
13.85x
EV/SALES RATIO AVG 20Y
13.34x
CURRENT VS TTM AVG
-24.74%
CURRENT VS 3Y AVG
-28.96%
CURRENT VS 5Y AVG
-25.80%
CURRENT VS 10Y AVG
-16.64%
CURRENT VS 15Y AVG
+0.16%
CURRENT VS 20Y AVG
+3.96%
ISRG Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 13.87x | 18.43x | 19.52x | 18.69x |
| Pfizer Inc. (PFE) | $146.36B | 3.31x | 3.30x | 3.43x | 3.63x |
| Gilead Sciences, Inc. (GILD) | $151.21B | 5.62x | 6.02x | 4.98x | 4.64x |
| Abbott Laboratories (ABT) | $154.66B | 4.04x | 4.94x | 5.00x | 4.98x |
| Danaher Corporation (DHR) | $130.25B | 5.81x | 6.63x | 7.16x | 7.00x |
| CVS Health Corporation (CVS) | $125.16B | 0.48x | 0.44x | 0.43x | 0.51x |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 3.08x | 2.99x | 3.12x | 3.48x |
| Thermo Fisher Scientific Inc. (TMO) | $179.45B | 4.87x | 5.13x | 5.38x | 5.62x |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 8.85x | 9.44x | 10.00x | 9.07x |
| Amgen Inc. (AMGN) | $183.75B | 6.19x | 6.19x | 6.53x | 6.39x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Intuitive Surgical, Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Intuitive Surgical, Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Intuitive Surgical, Inc. (ISRG)?
- The EV/Sales ratio for ISRG stock is 13.87x.
- Is Intuitive Surgical, Inc.'s EV/Sales ratio high or low?
- Intuitive Surgical, Inc.'s EV/Sales ratio of 13.87x is 26% below its 5-year average of 18.69x, near the low end of its 5-year range (10.91x–27.84x).
- What is the TTM average EV/Sales ratio for Intuitive Surgical, Inc. (ISRG)?
- The TTM average EV/Sales ratio for ISRG stock is 18.43x.
- What is the 3Y average EV/Sales ratio for Intuitive Surgical, Inc. (ISRG)?
- The 3Y average EV/Sales ratio for ISRG stock is 19.52x.
- What is the 5Y average EV/Sales ratio for Intuitive Surgical, Inc. (ISRG)?
- The 5Y average EV/Sales ratio for ISRG stock is 18.69x.
- What is the 10Y average EV/Sales ratio for Intuitive Surgical, Inc. (ISRG)?
- The 10Y average EV/Sales ratio for ISRG stock is 16.64x.
- What is the 15Y average EV/Sales ratio for Intuitive Surgical, Inc. (ISRG)?
- The 15Y average EV/Sales ratio for ISRG stock is 13.85x.
- What is the 20Y average EV/Sales ratio for Intuitive Surgical, Inc. (ISRG)?
- The 20Y average EV/Sales ratio for ISRG stock is 13.34x.
Intuitive Surgical, Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-10 | 13.87x |
| 2026-06-09 | 14.31x |
| 2026-06-08 | 14.04x |
| 2026-06-05 | 14.16x |
| 2026-06-04 | 14.05x |
| 2026-06-03 | 13.66x |
| 2026-06-02 | 13.49x |
| 2026-06-01 | 13.82x |
| 2026-05-29 | 14.25x |
| 2026-05-28 | 14.21x |
| 2026-05-27 | 14.04x |
| 2026-05-26 | 14.65x |
| 2026-05-22 | 14.70x |
| 2026-05-21 | 14.76x |
| 2026-05-20 | 15.07x |
| 2026-05-19 | 14.82x |
| 2026-05-18 | 14.77x |
| 2026-05-15 | 14.13x |
| 2026-05-14 | 14.36x |
| 2026-05-13 | 14.51x |
| 2026-05-12 | 14.49x |
| 2026-05-11 | 14.09x |
| 2026-05-08 | 15.11x |
| 2026-05-07 | 15.23x |
| 2026-05-06 | 15.17x |
| 2026-05-05 | 15.15x |
| 2026-05-04 | 15.19x |
| 2026-05-01 | 15.37x |
| 2026-04-30 | 15.37x |
| 2026-04-29 | 15.24x |
| 2026-04-28 | 15.67x |
| 2026-04-27 | 15.82x |
| 2026-04-24 | 16.20x |
| 2026-04-23 | 16.09x |
| 2026-04-22 | 16.25x |
| 2026-04-21 | 15.86x |
| 2026-04-20 | 16.37x |
| 2026-04-17 | 16.50x |
| 2026-04-16 | 16.10x |
| 2026-04-15 | 16.47x |
| 2026-04-14 | 16.43x |
| 2026-04-13 | 16.13x |
| 2026-04-10 | 15.83x |
| 2026-04-09 | 15.99x |
| 2026-04-08 | 16.25x |
| 2026-04-07 | 15.91x |
| 2026-04-06 | 15.90x |
| 2026-04-02 | 15.88x |
| 2026-04-01 | 16.33x |
| 2026-03-31 | 16.20x |
| 2026-03-30 | 15.91x |
| 2026-03-27 | 15.90x |
| 2026-03-26 | 16.47x |
| 2026-03-25 | 16.52x |
| 2026-03-24 | 16.59x |
| 2026-03-23 | 16.81x |
| 2026-03-20 | 16.81x |
| 2026-03-19 | 16.88x |
| 2026-03-18 | 16.80x |
| 2026-03-17 | 16.98x |
| 2026-03-16 | 17.01x |
| 2026-03-13 | 16.60x |
| 2026-03-12 | 16.86x |
| 2026-03-11 | 17.34x |
| 2026-03-10 | 17.09x |
| 2026-03-09 | 17.37x |
| 2026-03-06 | 17.25x |
| 2026-03-05 | 17.48x |
| 2026-03-04 | 17.64x |
| 2026-03-03 | 17.51x |
| 2026-03-02 | 17.47x |
| 2026-02-27 | 17.73x |
| 2026-02-26 | 17.85x |
| 2026-02-25 | 17.82x |
| 2026-02-24 | 17.39x |
| 2026-02-23 | 17.32x |
| 2026-02-20 | 17.74x |
| 2026-02-19 | 17.58x |
| 2026-02-18 | 17.63x |
| 2026-02-17 | 17.36x |
| 2026-02-13 | 17.09x |
| 2026-02-12 | 16.83x |
| 2026-02-11 | 17.46x |
| 2026-02-10 | 17.43x |
| 2026-02-09 | 17.34x |
| 2026-02-06 | 17.18x |
| 2026-02-05 | 16.75x |
| 2026-02-04 | 16.83x |
| 2026-02-03 | 16.84x |
| 2026-02-02 | 18.41x |
| 2026-01-30 | 18.69x |
| 2026-01-29 | 18.81x |
| 2026-01-28 | 19.36x |
| 2026-01-27 | 19.47x |
| 2026-01-26 | 19.61x |
| 2026-01-23 | 19.43x |
| 2026-01-22 | 19.50x |
| 2026-01-21 | 19.42x |
| 2026-01-20 | 19.56x |
| 2026-01-16 | 19.85x |
| 2026-01-15 | 20.08x |
| 2026-01-14 | 20.29x |
| 2026-01-13 | 20.86x |
| 2026-01-12 | 21.27x |
| 2026-01-09 | 21.77x |
| 2026-01-08 | 21.73x |
| 2026-01-07 | 22.00x |
| 2026-01-06 | 22.02x |
| 2026-01-05 | 21.03x |
| 2026-01-02 | 20.86x |
| 2025-12-31 | 21.03x |
| 2025-12-30 | 21.26x |
| 2025-12-29 | 21.37x |
| 2025-12-26 | 21.46x |
| 2025-12-24 | 21.43x |
| 2025-12-23 | 21.44x |
| 2025-12-22 | 21.53x |
| 2025-12-19 | 21.26x |
| 2025-12-18 | 20.86x |
| 2025-12-17 | 20.67x |
| 2025-12-16 | 20.58x |
| 2025-12-15 | 20.77x |
| 2025-12-12 | 20.12x |
| 2025-12-11 | 20.31x |
| 2025-12-10 | 20.63x |
| 2025-12-09 | 20.72x |
| 2025-12-08 | 21.05x |
| 2025-12-05 | 21.36x |
| 2025-12-04 | 21.11x |
| 2025-12-03 | 21.15x |
| 2025-12-02 | 21.08x |
| 2025-12-01 | 21.06x |
| 2025-11-28 | 21.29x |
| 2025-11-26 | 21.32x |
| 2025-11-25 | 21.50x |
| 2025-11-24 | 21.11x |
| 2025-11-21 | 20.85x |
| 2025-11-20 | 20.49x |
| 2025-11-19 | 20.96x |
| 2025-11-18 | 20.29x |
| 2025-11-17 | 20.29x |
| 2025-11-14 | 20.39x |
| 2025-11-13 | 20.99x |
| 2025-11-12 | 21.26x |
| 2025-11-11 | 21.24x |
| 2025-11-10 | 21.40x |
| 2025-11-07 | 20.79x |
| 2025-11-06 | 20.33x |
| 2025-11-05 | 20.36x |
| 2025-11-04 | 19.99x |
| 2025-11-03 | 20.19x |
| 2025-10-31 | 19.82x |
| 2025-10-30 | 19.66x |
| 2025-10-29 | 19.94x |
| 2025-10-28 | 20.24x |
| 2025-10-27 | 20.46x |
| 2025-10-24 | 20.28x |
| 2025-10-23 | 20.46x |
| 2025-10-22 | 19.55x |
| 2025-10-21 | 18.05x |
| 2025-10-20 | 17.88x |
| 2025-10-17 | 17.39x |
| 2025-10-16 | 16.93x |
| 2025-10-15 | 16.97x |
| 2025-10-14 | 17.00x |
| 2025-10-13 | 16.98x |
| 2025-10-10 | 16.73x |
| 2025-10-09 | 17.30x |
| 2025-10-08 | 17.47x |
| 2025-10-07 | 17.18x |
| 2025-10-06 | 17.53x |
| 2025-10-03 | 17.64x |
| 2025-10-02 | 17.27x |
| 2025-10-01 | 17.07x |
| 2025-09-30 | 17.43x |
| 2025-09-29 | 17.12x |
| 2025-09-26 | 17.19x |
| 2025-09-25 | 17.07x |
| 2025-09-24 | 17.30x |
| 2025-09-23 | 17.45x |
| 2025-09-22 | 17.33x |
| 2025-09-19 | 17.10x |
| 2025-09-18 | 16.98x |
| 2025-09-17 | 16.89x |
| 2025-09-16 | 16.93x |
| 2025-09-15 | 16.91x |
| 2025-09-12 | 17.53x |
| 2025-09-11 | 17.78x |
| 2025-09-10 | 17.54x |
| 2025-09-09 | 18.24x |
| 2025-09-08 | 18.34x |
| 2025-09-05 | 18.22x |
| 2025-09-04 | 17.72x |
| 2025-09-03 | 17.19x |
| 2025-09-02 | 18.30x |
| 2025-08-29 | 18.47x |
| 2025-08-28 | 18.49x |
| 2025-08-27 | 18.39x |
| 2025-08-26 | 18.51x |
| 2025-08-25 | 18.28x |
| 2025-08-22 | 18.59x |
| 2025-08-21 | 18.34x |
| 2025-08-20 | 18.76x |
| 2025-08-19 | 18.71x |
| 2025-08-18 | 18.79x |
| 2025-08-15 | 18.75x |
| 2025-08-14 | 18.62x |
| 2025-08-13 | 18.83x |
| 2025-08-12 | 18.67x |
| 2025-08-11 | 18.41x |
| 2025-08-08 | 18.34x |
| 2025-08-07 | 18.33x |
| 2025-08-06 | 18.50x |
| 2025-08-05 | 18.62x |
| 2025-08-04 | 18.87x |
| 2025-08-01 | 18.86x |
| 2025-07-31 | 18.78x |
| 2025-07-30 | 19.56x |
| 2025-07-29 | 19.41x |
| 2025-07-28 | 19.29x |
| 2025-07-25 | 19.37x |
| 2025-07-24 | 19.08x |
| 2025-07-23 | 19.61x |
| 2025-07-22 | 21.08x |
| 2025-07-21 | 21.30x |
| 2025-07-18 | 21.40x |
| 2025-07-17 | 21.30x |
| 2025-07-16 | 21.15x |
| 2025-07-15 | 21.13x |
| 2025-07-14 | 21.31x |
| 2025-07-11 | 21.13x |
| 2025-07-10 | 21.71x |
| 2025-07-09 | 21.80x |
| 2025-07-08 | 21.76x |
| 2025-07-07 | 22.08x |
| 2025-07-03 | 22.48x |
| 2025-07-02 | 22.32x |
| 2025-07-01 | 22.21x |
| 2025-06-30 | 22.44x |
| 2025-06-27 | 22.03x |
| 2025-06-26 | 22.05x |
| 2025-06-25 | 21.53x |
| 2025-06-24 | 21.59x |
| 2025-06-23 | 21.25x |
| 2025-06-20 | 21.01x |
| 2025-06-18 | 21.02x |
| 2025-06-17 | 21.13x |
| 2025-06-16 | 21.42x |
| 2025-06-13 | 21.13x |
| 2025-06-12 | 21.17x |
| 2025-06-11 | 21.56x |
| 2025-06-10 | 21.86x |
| 2025-06-09 | 21.72x |
| 2025-06-06 | 23.01x |
| 2025-06-05 | 23.05x |
| 2025-06-04 | 23.05x |
| 2025-06-03 | 22.79x |
| 2025-06-02 | 22.85x |
| 2025-05-30 | 22.81x |
| 2025-05-29 | 22.96x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa